Patent ID: 8093302

Claim:
A compound selected from the group consisting of: 9-(4-Hydroxy-phenyl)-4b,5,6,7,8,8a,9,10-octahydro-phenanthren-3-ol; 4-(4-Hydroxy-phenyl)-2,3,3a,4,5,9b-hexahydro-1H-cyclopenta[a]naphthalen-8-ol; 9-(4-Hydroxy-phenyl)-4b,5,6,7,8,8a,9,10-octahydro-phenanthrene-1,3-diol; 9-(4-Hydroxy-phenyl-1-methoxymethyl-4b,5,6,7,8,8a,9,10-octahydro-phenanthren-3-ol; 1-Hydroxymethyl-9-(4-hydroxy-phenyl)-4b,5,6,7,8,8a,9,10-octahydro-phenanthren-3-ol; [3 -Hydroxy-9-(4-hydroxy-phenyl)-4b,5 ,6,7,8, 8a,9,10-octahydro-phenanthren- 1-yl]-acetonitrile; 3-Hydroxy-9-(4-hydroxy-phenyl)-4b,5,6,7,8,8a,9,10-octahydro-phenanthrene-1-carbonitrile; 9-(4-Hydroxy-phenyl)-4b,5,6,7,8,8a,9,10-octahydro-phenanthrene-2,3-diol; 9-(4-Hydroxy-phenyl)-2-methoxy-4b,5,6,7,8,8a,9,10-octahydro-phenanthren-3-ol; 9-(4-Hydroxy-phenyl)-2-methoxymethyl-4b,5,6,7,8,8a,9,10-octahydro-phenanthren-3-ol; [6-Hydroxy-10-(4-hydroxy-phenyl)-1,2,3,4,4a,9,10,10a-octahydro-phenanthrene-9-yl]-acetonitrile; or a pharmaceutically acceptable salt thereof.